Xiaoxian Li MD, PhD

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 25

  1. 1
  2. 2
  3. 3

Article

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

by Tejal A. Patel; Joe E. Ensor; Sarah L. Creamer; Toniva Boone; Angel A. Rodriguez; Poly A. Niravath; Jorge G. Darcourt; Jane L. Meisel; Xiaoxian Li; Jing Zhao; John G. Kuhn; Roberto R. Rosato; Wei Qian; Anna Belcheva; Mary R. Schwartz; Virginia G. Kaklamani; Jenny C. Chang

2019

Article

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study

by Shristi Bhattarai; Sergey Klimov; Karuna Mittal; Uma Krishnamurti; Xiaoxian Li; Gabriela Oprea; Ceyda Sonmez Wetherilt; Ansa Riaz; Mohammed A. Aleskandarany; Andrew R. Green; Ian O. Ellis; Guilherme Cantuaria; Meenakshi Gupta; Upender Manne; Johnson Agboola; Brett Baskovich; Emiel A. M. Janssen; Grace Callagy; Elaine M. Walsh; Anurag Mehta; Atika Dogra; Tanuja Shet; Pooja Gajaria; Tiffany Traina; Haruna A. Nggada; Abidemi Omonisi; Saad A. Ahmed; Emad A. Rakha; Padmashree Rida; Ritu Aneja

2019

Article

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer

by Chakravarthy Garlapati; Shriya Joshi; Shristi Bhattarai; Jayashree Krishnamurthy; Ravi Chakra Turaga; Thi Nguyen; Xiaoxian Li; Ritu Aneja

2023

Article

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

by Kai Sun; Yitian Xu; Licheng Zhang; Polly Niravath; Jorge Darcourt; Tejal Patel; Bin S Teh; Andrew M Farach; Carlo Guerrero; Sunil Mathur; Mark A Sultenfuss; Nakul Gupta; Mary R Schwartz; Susan L Haley; Sindhu Nair; Xiaoxian Li; Thi Truc Anh Nguyen; Joseph D Butner; Joe Ensor; Jaime A Mejia; Zhuyong Mei; Brian E Butler; Shu-Hsia Chen; Eric H Bernicker; Jenny C Chang

2022

Article

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome

by Xiaoxian Li; RYS Cheng; LA Ridnour; AL Wink; AL Gonzalez; EL Femino; H Rittscher; V Somasundaram; WF Heinz; L Coutinho; MC Rangel; EF Edmondson; D Butcher; RJ Kinders; STC Wong; DW McVicar; SK Anderson; M Pore; SM Hewitt; TR Billiar; SA Glynn; JC Chang; SJ Lockett; S Ambs; DA Wink

2023

Article

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

by Clinton Yam; Nour Abuhadra; Ryan Sun; Beatriz E Adrada; Qing-Qing Ding; Jason B White; Elizabeth E Ravenberg; Alyson R Clayborn; Vicente Valero; Debu Tripathy; Senthilkumar Damodaran; Banu K Arun; Jennifer K Litton; Naoto T Ueno; Rashmi K Murthy; Bora Lim; Luis Baez; Xiaoxian Li; Aman U Buzdar; Gabriel N Hortobagyi; Alistair AM Thompson; Elizabeth A. Mittendori; Gaiane M Rauch; Rosalind P Candelaria; Lei Huo; Stacy L Moulder; Jeffrey T Chang

2022

Article

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study

by Joseph D Butner; Prashant Dogra; Caroline Chung; Javier Ruiz-Ramirez; Sara Nizzero; Marija Plodinec; Xiaoxian Li; Ping-Ying Pan; Shu-hsia Chen; Vittorio Cristini; Bulent Ozpolat; George A Calin; Zhihui Wang

2022

Article

Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer

by Victor Garcia; Katherine Elfer; Dieter JE Peeters; Anna Ehinger; Bruce Werness; Amy Ly; Xiaoxian Li; Matthew G Hanna; Kim RM Blenman; Roberto Salgado; Brandon D Gallas

2022